ZBiotics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $12M

  • Investors
  • 28

ZBiotics General Information

Description

Developer of genetically engineered probiotics designed to let the body handle everything from everyday chemicals in alcohol and dairy to serious contaminants. The company offers a genetically engineered probiotic drink that breaks down acetaldehyde, an unwanted byproduct of alcohol, enabling users to prevent the worst next-day effects of drinking.

Contact Information

Website
www.zbiotics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 44 Montgomery Street
  • 3rd Floor
  • San Francisco, CA 94104
  • United States
+1 (415)
Primary Industry
Beverages
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 44 Montgomery Street
  • 3rd Floor
  • San Francisco, CA 94104
  • United States
+1 (415)

ZBiotics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ZBiotics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 27-Aug-2024 $12M Completed Generating Revenue
5. Later Stage VC (Series A) 09-Apr-2024 Completed Generating Revenue
4. Accelerator/Incubator 12-Jan-2021 Completed Generating Revenue
3. Seed Round 23-Mar-2020 Completed Generating Revenue
2. Product Crowdfunding 22-Sep-2018 $52K $120K Completed Generating Revenue
1. Accelerator/Incubator 20-Mar-2018 $120K $120K Completed Generating Revenue
To view ZBiotics’s complete valuation and funding history, request access »

ZBiotics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A-4
Series A-3
Series A-2
Seed-3
Seed-2 1,512,998 $0.000010 $0.64 $0.64 1x $0.64 4.73%
Seed-1 4,194,788 $0.000010 $1.05 $1.05 1x $1.05 13.11%
To view ZBiotics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ZBiotics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genetically engineered probiotics designed to let the body handle everything from everyday chemicals in alc
Beverages
San Francisco, CA
44 As of 2024

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ZBiotics Competitors (1)

One of ZBiotics’s competitors is Cheers, a Venture Capital-Backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cheers Venture Capital-Backed Houston, TX
You’re viewing 1 of 1 competitors. Get the full list »

ZBiotics Patents

  • 26

    Total Documents Applications and Grants

  • Total Patents Families

  • 14

    Granted

  • 12

    Pending

  • Expiring in next 12 mo

ZBiotics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021358080-A1 Engineered probiotics for expression of fiber-synthesizing enzymes in gut Pending 08-Oct-2020
EP-4225338-A1 Engineered probiotics for expression of fiber-synthesizing enzymes in gut Pending 08-Oct-2020
GB-202306208-D0 Engineered probiotics for expression of fiber-synthesizing enzymes in gut Pending 08-Oct-2020
GB-2616358-A Engineered probiotics for expression of fiber-synthesizing enzymes in gut Pending 08-Oct-2020
CA-3194677-A1 Engineered probiotics for expression of fiber-synthesizing enzymes in gut Pending 08-Oct-2020 C12N15/75
To view ZBiotics’s complete patent history, request access »

ZBiotics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ZBiotics Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds
Seamless Capital Venture Capital Minority
Springtide Venture Capital Minority
Able Partners Venture Capital Minority
Access Capital (Dallas) Growth/Expansion Minority
Claridge Venture Partners Family Office Minority
You’re viewing 5 of 28 investors. Get the full list »

Ready to get started?

Request a free trial

ZBiotics FAQs

  • When was ZBiotics founded?

    ZBiotics was founded in 2016.

  • Where is ZBiotics headquartered?

    ZBiotics is headquartered in San Francisco, CA.

  • What is the size of ZBiotics?

    ZBiotics has 44 total employees.

  • What industry is ZBiotics in?

    ZBiotics’s primary industry is Beverages.

  • Is ZBiotics a private or public company?

    ZBiotics is a Private company.

  • What is ZBiotics’s current revenue?

    The current revenue for ZBiotics is .

  • How much funding has ZBiotics raised over time?

    ZBiotics has raised $40.3M.

  • Who are ZBiotics’s investors?

    Seamless Capital, Springtide, Able Partners, Access Capital (Dallas), and Claridge Venture Partners are 5 of 28 investors who have invested in ZBiotics.

  • Who are ZBiotics’s competitors?

    Cheers is a competitor of ZBiotics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »